Scientists are starting to get insights into the lingering disorder that affects some people infected with SARS-CoV-2. There is increasing clarity on the overall prevalence of long COVID, thanks to a series of surveys — but it is less certain who is most at risk, and why it affects only some.
Special Thanks
- René Najera, DrPH. Senior Epidemiologist
- Dr. Ralph J. DiClemente, Chair NYU School of Social and Behavioral Sciences
- Dr Neurofourier
- Puneet Singh, PKS Law Group
- Dr Maureen Miller, PhD, Epidemiologist, Columbia University
- Dr John Mattison, Arsenal Capital Partners
- Edward Nirenberg
- Resolve to Save Lives
- X-Prize
- Robert Holdheim
- Vivienne Ming, Socos Lab
- Natalie Sarkic-Todd, TheBattleground.eu
- Jeff Chertack, Gates Foundation
- Mrigank Shail MD, WHO
- Dr Obinna Onyekwena, Global Fund
- Dr. Glennis Mehra, Biolabs@NYULangone
- Jane Sloan, Asia Foundation
- Pandemic Action Network
- Simon Lester, World Trade Law
- Jas Charanjiva
- Reuben Abraham, IDFC
Covidpedia Labs offers public health information on the COVID 19 pandemic for your general knowledge. This information does not replace written law or professional medical advice, diagnosis, or treatment. It is intended to raise awareness on COVID-19 for public use and consumption. If you have questions from the information you have read on this site regarding a medical condition, access to medicine and/or vaccines, always seek the professional advice of a doctor or other qualified health professionals. All copyrighted content is labeled. If you’d like to share copyrighted content, contact the owner of that material.